vimarsana.com
Home
Live Updates
Hypothesized Ability - Breaking News
Pages:
Hypothesized Ability News Today : Breaking News, Live Updates & Top Stories | Vimarsana
EQS-News: Immunic, Inc : Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders
Issuer: Immunic, Inc. / Key word(s): Study results Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic
United states
New zealand
Edna kaplan
Daniel vitt
Jessica breu
Andreas muehler
Paula schwartz
Gut health
Distribution services
Rx communications group
Exchange commission
Immunic inc
Reports positive results from phase
Clinical trial
Celiac disease
Providing clinical proof of concept
vimarsana © 2020. All Rights Reserved.